# Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France

Laila Toro, Henriette de Valk, Laura Zanetti, Caroline Huot, Arnaud

Tarantola, Nelly Fournet, Laurent Moulin, Ali Atoui, Benoît Gassilloud, Damien Mouly, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Laila Toro, Henriette de Valk, Laura Zanetti, Caroline Huot, Arnaud Tarantola, et al. Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France. Eurosurveillance, 2024, 29 (28), 10.2807/1560-7917.es.2024.29.28.2400231. anses-04865544

HAL Id: anses-04865544

https://anses.hal.science/anses-04865544v1

Submitted on 6 Jan 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France

Laila Toro¹, Henriette de Valk², Laura Zanetti², Caroline Huot³, Arnaud Tarantola⁴, Nelly Fournet⁴, Laurent Moulin⁵, Ali Atoui⁶,
Benoît Gassilloud⁶, Damien Mouly⁷,* , Frédéric Jourdain¹,.*

1. Santé publique France (French National Public Health Agency), Montpellier, France

2. Santé publique France (French National Public Health Agency), Saint-Maurice, France

3. Institut national de santé publique du Québec, Québec, Canada

4. Santé publique France (French National Public Health Agency), Saint-Denis, France

5. Eau de Paris, Ivry-sur-Seine, France

6. ANSES Nancy Laboratory for Hydrology, Nancy, France

7. Santé publique France (French National Public Health Agency), Toulouse, France

Correspondence: Laila Toro (laila.toro@santepubliquefrance.fr)

**Citation style for this article:**

Toro Laila, de Valk Henriette, Zanetti Laura, Huot Caroline, Tarantola Arnaud, Fournet Nelly, Moulin Laurent, Atoui Ali, Gassilloud Benoît, Mouly Damien, Jourdain Frédéric. Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France. Euro Surveill. 2024;29(28):pii=2400231. https://doi.org/10.2807/1560-7917.ES.2024.29.28.2400231

Article received on 16 Apr 2024 / Accepted on 17 Jun 2024 / Published on 11 Jul 2024

**Background:** Wastewater surveillance is an effective approach to monitor population health, as exemplified by its role throughout the COVID-19 pandemic.

**Aim:** This study explores the possibility of extending wastewater surveillance to the Paris 2024 Olympic and Paralympic Games, focusing on identifying priority pathogen targets that are relevant and feasible to monitor in wastewater for these events.
**Methods:** A list of 60 pathogens of interest for general public health surveillance for the Games was compiled.

Each pathogen was evaluated against three inclusion criteria: (A) analytical feasibility; (B) relevance, i.e. with regards to the specificities of the event and the characteristics of the pathogen; and (C) added value to inform public health decision-making. Analytical feasibility was assessed through evidence from peer-reviewed publications demonstrating the detectability of pathogens in sewage, refining the initial list to 25 pathogens. Criteria B and C were evaluated via expert opinion using the Delphi method. The panel consisting of some 30 experts proposed five additional pathogens meeting criterion A, totalling 30 pathogens assessed throughout the three-round iterative questionnaire.

Pathogens failing to reach 70% group consensus threshold underwent further deliberation by a subgroup of experts. **Results:** Six priority targets suitable for wastewater surveillance during the Games were successfully identified: poliovirus, influenza A virus, influenza B virus, mpox virus, SARS-CoV-2 and measles virus. **Conclusion:** This study introduced a model framework for identifying context-specific wastewater surveillance targets for a mass gathering. Successful implementation of a wastewater surveillance plan for

Paris 2024 could incentivise similar monitoring efforts for other mass gatherings globally.

## Introduction

Wastewater acts as a 'mirror' of population health. Through the analysis of sewage samples, wastewater-based epidemiology (WBE) provides information on substance consumption (licit and illicit drugs, tobacco and alcohol), chemical exposure and the circulation of certain pathogens within a population [1,2]. While it gained considerable momentum during the COVID-19 pandemic, wastewater surveillance (WWS) is not a new concept. The tool has been used to follow waterborne or faecal-oral transmitted pathogens such as the poliovirus for several decades [1,3]. Nonetheless, since it was proven in 2020 that the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be detected in wastewater and that its quantification correlated with COVID-19 cases, the field of WBE and its methods have developed considerably [1,4]. The environmental surveillance of SARS-CoV-2 offers many advantages, as it: (i) collects data regardless of health status (symptomatic, asymptomatic); (ii) is not influenced by the availability of testing or test-seeking behaviour; (iii) can act as an early warning system; (iv) is cost-effective and (v) provides community-level data in a passive and non-intrusive manner [1,2,4]. Further, with the progression of the COVID-19 pandemic and emergence of SARS-CoV-2 variants of concern, WWS objectives have expanded beyond the mere detection of virus presence and monitoring of trends to include virus quantification and the assessment of genetic diversity. Indeed, wastewater data has been used

<figure><img src="image_3.png" /></figure>

<footnote>* These authors contributed equally to this work and share last authorship.</footnote>
# KEY PUBLIC HEALTH MESSAGE

## What did you want to address in this study and why?

The growing body of evidence on the effective use of wastewater surveillance (WWS) to monitor population health highlights its potential for broader application. We explored the possibility of extending WWS to the Paris 2024 Olympic and Paralympic Games. Our aim was to identify relevant and feasible pathogen targets for WWS during these mass gathering events while using a reproducible, transparent and qualitative framework.

## What have we learnt from this study?

Using evidence from peer-reviewed publications and expert opinion, six priority pathogen targets suitable for WWS during the Paris 2024 Olympic and Paralympic Games were successfully identified: poliovirus, influenza A virus, influenza B virus, mpox virus, SARS-CoV-2 and measles virus.

## What are the implications of your findings for public health?

This study introduced a model framework for identifying context-specific WWS targets for mass gatherings and offered a starting point for WWS planning for the Paris 2024 Olympic and Paralympic Games. If successful, WWS for the Games and the lessons learned from its design and implementation could serve as an incentive for the adoption of WWS during other mass gathering events worldwide.

extensively to complement other population-based surveillance systems and can help guide public health decision-making [1,3-5]. The success of WBE over the last few years has raised questions about the possibilities of extending this surveillance to other infectious agents and contexts. One such example is the public health surveillance of mass gathering (MG) events.

The World Health Organization (WHO) characterises an MG as an event where the volume of attendees can stretch the planning and response capabilities of the community, state or nation hosting the event [6]. Such gatherings have inherent characteristics that place them at greater risk of infectious disease transmission. Mass gathering events involve the concentration of large numbers of people in the same place at the same time, which facilitates pathogen dissemination. These gatherings may also see a considerable influx of international travellers, increasing the risk of disease importation [6,7]. Travellers may also exhibit modified individual health seeking behaviours because of cost, language barriers and/or lack of familiarity with the healthcare system on location. Although rare, notable examples of epidemics related to MGs have been described in the literature [6,8-11]. Moreover, an epidemic occurring during an international MG has a greater potential to be exported from the host country, and therefore of becoming a cross-border health issue [6]. From 26 July to 8 September 2024, France will host the Olympic and Paralympic Games (OPG), the two largest international sporting MG events. The Paris 2024 OPG are expected to bring over 15.9 million visitors cumulatively and will be the largest sporting events held in the country to date [12,13]. In this context, France's public health preparedness is being adapted, notably by reinforcing

health monitoring and epidemiological surveillance. The inclusion of WWS as a component of the enhanced surveillance system under development for the Paris Games was suggested.

This study sought to identify priority pathogen targets that are both relevant and feasible to monitor in wastewater during the Paris 2024 Games, while using a reproducible, transparent and qualitative framework. It constitutes the first step taken towards the conception and planning of a WWS strategy for Paris 2024.

## Methods

### Identification of pathogens/diseases for public health surveillance

To identify pathogens/diseases of interest for general public health surveillance (non-wastewater-specific) for the 2024 OPG, a preliminary list of pathogens/diseases of relevance for the surveillance of MGs was compiled by the authors of this manuscript using the following criteria (Box).

The pathogens/diseases listed were then associated to disease categories identified as priorities for the Games by France's national public health agency (Santé publique France, SpF) in a risk map created for the event. These categories included notifiable diseases in France, pathogens associated with food poisoning and/or food-borne illness outbreaks, acute respiratory infections, emerging infectious diseases and zoonoses. Only pathogens/diseases from the preliminary list that fit into these groups were retained. These, along with six additional infectious diseases identified specifically by SpF (brucellosis, West Nile fever, mpox, Venezuelan equine encephalitis, glanders and

<figure><img src="image_4.png" /></figure>
i. pathogens and diseases identified by ECDC as surveillance priorities for the London 2012 and Rio de Janeiro 2016 OPG [7,40].

ii. infectious diseases identified as requiring increased surveillance for the Tokyo 2020 OPG following risk assessments performed by the 47 districts in Japan hosting Olympic training centres and sporting events [41].

iii. infectious diseases that have caused epidemics at previous OPGs, from the 2002 Winter OPG in Salt Lake City to the 2020 Summer OPG in Tokyo [7,37,38].

iv. infectious diseases identified by the WHO as presenting the greatest risk to public health because of their epidemic potential and/or the absence or insufficiency of countermeasures [39].

ECDC: European Centre for Disease Prevention and Control; OPG: Olympic and Paralympic Games; WHO: World Health Organization.

echinococcosis), were compiled into a list of pathogens to be considered for WWS during the Paris 2024 OPG.

## Framework for identifying priority pathogen targets for wastewater surveillance

Not all pathogens are adapted and relevant targets for WWS, especially during an MG event like the Paris 2024 OPG. To identify priority targets in this context, candidate pathogens identified in the previous step were evaluated against three inclusion criteria: (A) analytical feasibility; (B) relevance, i.e. with regards to the specificities of the event and the characteristics of the pathogen; and (C) added value to inform public health decision-making (Figure 1). This methodology was adapted from similar approaches used to prioritise pathogens for WWS in other contexts [4,14].

To be monitored in wastewater, pathogens must be excreted in the urine and/or faeces of infected individuals or introduced into sewage via greywater, i.e. from showers and other hygiene activities. Pathogens must also persist in the environment long enough to be detectable by existing analytical methods [4,15,16]. We considered analytical feasibility (criterion A) to be met if there was scientific evidence supported by at least one peer-reviewed publication that a pathogen has been detected in wastewater previously. The articles in question are provided in Supplementary Table S1, a table of key information on potential pathogens. This first criterion was evaluated via a literature search conducted using the PubMed database in March 2023. An example of the search query used is available in Supplement S1. Papers referencing spiked samples, open sewer systems or that sampled hospital effluents exclusively were excluded to better reflect the conditions that will be observed during the Paris 2024 Games.

Event- and pathogen-specific (and associated disease-specific) characteristics influence the relevance of implementing WWS for a pathogen. Further, to be retained, wastewater monitoring must add value to

public health decision-making with regards to population-based surveillance already in place, i.e. nationally notifiable diseases, sentinel surveillance, emergency department admission rates, screening tests data, etc. To evaluate inclusion criteria B and C and establish a list of priority targets for WWS for the 2024 OPG, expert opinion was solicited using the Delphi method.

## Delphi method

A Delphi survey is a method for the systematic solicitation of opinions from a panel of experts on a particular topic. It aims to achieve consensus through a structured, anonymous process involving an iterative series of questionnaires. For our study, after each round, the questionnaire was adapted and pathogens for which consensus was reached were removed. Panellists also received the aggregated responses of respondents from the previous round and were given the opportunity to re-evaluate their own answers on this basis, revising them when deemed appropriate [17].

Experts were selected based on their professional background and complementary expertise in the fields of public health (with a focus on infectious diseases), WBE, microbiology and drinking-water/wastewater treatment. They were recruited from eight different organisations at the regional and national level in France, as well as one from Canada, and invited to participate via email. To mitigate potential bias related to the different states of knowledge of panellists on potential surveillance targets and to help inform pathogen evaluation, a summary of key information relating to pathogens that satisfied the analytical feasibility criterion, was prepared (provided as Supplementary Table S1). Only those experts having completed a round of the survey were invited to participate in its subsequent iteration.

Panellists were asked to judge whether pathogens would constitute suitable targets for wastewater monitoring during the Paris 2024 OPG. In line with previous studies [17], we considered group consensus reached when there was a convergence in expert opinion ≥70%

<figure><img src="image_5.png" /></figure>
FIGURE 1

Framework for identifying priority targets for wastewater surveillance among pathogens deemed of interest for general public health surveillance during the Paris 2024 Olympic and Paralympic Games, France

<figure><img src="image_6.png" /></figure>

The figure is adapted from [4].

with regards to a pathogen's inclusion or exclusion from this surveillance. To be judged favourably, a participant needed to be convinced that the pathogen in question satisfied all three inclusion criteria listed above. When deemed suitable, experts were questioned on the pathogen's most pertinent WWS objective(s), among: (i) detection (presence/absence); (ii) quantification; (iii) trend monitoring and (iv) assessment of genetic diversity. Alternatively, for pathogens they suggested to exclude from this surveillance, panellists were asked to justify their decision. At this stage, the relevance criterion was subcategorised into 'relevance with regard to the specificities of the event' and 'relevance with regard to pathogen-/disease-specific characteristics'. The Delphi method took place over a nearly 3-month period from 3 May to 25 July 2023.

Pathogens failing to meet criterion A (i.e. analytical feasibility) because of a lack of evidence of detectability in wastewater were assembled in a catalogue of prospective pathogens for wastewater research. Participants were then tasked with identifying which among these should constitute priority research targets for the development of detection/quantification methods. Finally, experts were questioned about the need to consider other pathogens for this surveillance. An example of the questions asked for each infectious agent evaluated is available in Supplement S2.

The third round was set as the end of the iterative process, which corresponds to the standard duration of a Delphi process [17,18]. All data collected were treated anonymously. The electronic questionnaire was

created using LimeSurvey (version 5.6.54), and auto-administrated through an active link.

## Assessment of pathogens below the consensus threshold

Pathogens failing to reach the 70% consensus threshold at the end of the Delphi exercise, were reassessed collaboratively by a group of SpF epidemiologists in charge of France's national wastewater monitoring system (SUM'Eau). The following elements were considered: (i) proximity to the threshold for inclusion/exclusion; (ii) the pathogens' epidemiological, clinical and microbiological characteristics, as well as (iii) comments left by panellists.

## Results

A list of pathogens/diseases of interest for public health surveillance for the Paris 2024 OPG was produced (Table 1) and included 60 causative agents, the details of which are provided in Supplementary Table S1. Evaluation based on criterion A (i.e. analytical feasibility) reduced this list to 25 pathogens (Figure 2).

Of the 62 experts invited to take part in the about 3-month long Delphi exercise, 33 (53%) responded to rounds 1 and 2 and 32 (52%) completed all three rounds of the survey. Among the latter, 26 have a professional background in public health, specialising in infectious diseases, 12 in WBE, 9 in microbiology and 4 in drinking water and/or wastewater treatment. Of note, some experts have expertise in multiple fields.

Five pathogens (or categories of pathogens) meeting the analytical feasibility criterion (A) were also

<figure><img src="image_7.png" /></figure>
TABLE 1A

Pathogens/diseases of interest for public health surveillance during the Paris 2024 Olympic and Paralympic Games, France

<table><thead><tr><th rowspan="2">Pathogen/disease</th><th colspan="3">Communicable diseases deemed of relevance for increased surveillance activities following risk assessments</th><th rowspan="2">Infectious diseases occurrences in previous OPGs<sup>a</sup> [7,37,38]</th><th rowspan="2">Diseases posing the greatest public health risk (WHO) [39]</th><th colspan="4">Disease categories of interest identified by Santé publique France</th><th rowspan="2">Pathogens/ diseases of interest for public health surveillance during the Paris 2024 OPG</th></tr><tr><th>London 2012 OPG [40]</th><th>Rio de Janeiro 2016 OPG [7]</th><th>Tokyo 2020 OPG [41]</th><th>Notifiable diseases in France</th><th>Pathogens responsible for food poisoning/ food-borne illness outbreaks</th><th>Acute respiratory infections</th><th>Emerging infectious diseases</th><th>Zoonoses</th></tr></thead><tbody><tr><td colspan="11"><strong>Vaccine-preventable diseases</strong></td></tr><tr><td>Diphtheria</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Measles</td><td>1</td><td>1</td><td>1</td><td>1</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Meningococcal disease</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Mumps</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Pertussis</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Pneumococcal disease</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Poliomyelitis</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Rubella</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Typhoid fever (Typhoidal Salmonella)</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td colspan="11"><strong>Food- and waterborne diseases</strong></td></tr><tr><td>Amoebiasis</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Botulism</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td><strong>Brucellosis</strong></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td><em>Campylobacter</em> infection</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Cholera</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td><em>Escherichia coli</em> infection</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Hepatitis A</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Hepatitis E</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Human adenovirus-F</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Legionnaires' disease</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Norovirus</td><td>1</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Rotavirus</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Salmonellosis (nontyphoidal Salmonella)</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Shigellosis</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Yersiniosis</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Food poisoning/ gastrointestinal illness (unspecified)</td><td>-</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td colspan="11"><strong>Airborne diseases</strong></td></tr><tr><td>Influenza</td><td>1</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>1</td><td>1</td></tr><tr><td>MERS-CoV</td><td>-</td><td>-</td><td>1</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Tuberculosis</td><td>1</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>1</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Respiratory tract infection (unspecified or other)</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr></tbody></table>

OPG: Olympic and Paralympic Games; WHO: World Health Organization.

Infectious diseases highlighted in bold correspond to those identified specifically by Santé publique France as being of potential interest for public health surveillance during the Games.

<figure><img src="image_8.png" /></figure>

<footnote>a Infectious disease responsible for epidemics at previous OPGs, from the 2002 Winter OPG in Salt Lake City to the 2020 Summer OPG in Tokyo.</footnote>

<footnote>b Lassa fever only.</footnote>

<footnote>c Dengue, chikungunya and Zika virus disease are classified as 'zoonoses', though the viruses are believed to be maintained primarily in human/mosquito cycles, especially in urban areas.</footnote>
TABLE 1B

Pathogens/diseases of interest for public health surveillance during the Paris 2024 Olympic and Paralympic Games, France

<table><thead><tr><th rowspan="2">Pathogen/disease</th><th colspan="3">Communicable diseases deemed of relevance for increased surveillance activities following risk assessments</th><th rowspan="2">Infectious diseases occurrences in previous OPGs<sup>a</sup> [7,37,38]</th><th rowspan="2">Diseases posing the greatest public health risk (WHO) [39]</th><th colspan="4">Disease categories of interest identified by Santé publique France</th><th rowspan="2">Pathogens/ diseases of interest for public health surveillance during the Paris 2024 OPG</th></tr><tr><th>London 2012 OPG [40]</th><th>Rio de Janeiro 2016 OPG [7]</th><th>Tokyo 2020 OPG [41]</th><th>Notifiable diseases in France</th><th>Pathogens responsible for food poisoning/ food-borne illness outbreaks</th><th>Acute respiratory infections</th><th>Emerging infectious diseases</th><th>Zoonoses</th></tr></thead><tbody><tr><td colspan="11"><strong>Emerging and vector-borne diseases</strong></td></tr><tr><td>Arenavirus diseases (Lassa, Junin, Machupo, Guanarito, and Sabiá fever)</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1<sup>b</sup></td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Chikungunya</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1<sup>c</sup></td><td>1</td></tr><tr><td>COVID-19</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td><td>-</td><td>1</td><td>1</td><td>-</td><td>1</td></tr><tr><td>Crimean-Congo haemorrhagic fever</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Dengue</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1<sup>c</sup></td><td>1</td></tr><tr><td>Ebola or Marburg viruses (filoviruses)</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Invasive group A streptococcal infection</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Malaria</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Mpox</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Rift Valley fever</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Severe acute respiratory syndrome (SARS)</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>-</td><td>1</td></tr><tr><td>Smallpox</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Tularaemia</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Typhus</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>West Nile virus infection</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Yellow fever</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Zika virus disease</td><td>-</td><td>1</td><td>1</td><td>-</td><td>1</td><td>1</td><td>-</td><td>-</td><td>1</td><td>1<sup>c</sup></td><td>1</td></tr><tr><td colspan="11"><strong>Zoonoses</strong></td></tr><tr><td>Anthrax</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Echinococcosis</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Glanders</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Leptospirosis</td><td>1</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Nipah and henipaviral diseases</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Rabies</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td>Venezuelan equine encephalitis</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>1</td></tr><tr><td colspan="11"><strong>Sexually transmitted infections</strong></td></tr><tr><td>Chlamydia infection</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Hepatitis B</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Hepatitis C</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Human immunodeficiency virus infection</td><td>1</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td>Syphilis</td><td>1</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Genital infection (unspecified)</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td colspan="11"><strong>Other</strong></td></tr><tr><td>Disease X</td><td>-</td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr></tbody></table>

OPG: Olympic and Paralympic Games; WHO: World Health Organization.

Infectious diseases highlighted in bold correspond to those identified specifically by Santé publique France as being of potential interest for public health surveillance during the Games.

<figure><img src="image_9.png" /></figure>

<footnote>a Infectious disease responsible for epidemics at previous OPGs, from the 2002 Winter OPG in Salt Lake City to the 2020 Summer OPG in Tokyo.</footnote>

<footnote>b Lassa fever only.</footnote>

<footnote>c Dengue, chikungunya and Zika virus disease are classified as 'zoonoses', though the viruses are believed to be maintained primarily in human/mosquito cycles, especially in urban areas.</footnote>
proposed by the panel for evaluation: non-polio Enteroviruses, *Cryptosporidium spp.*, *Giardia duodenalis*, Alphacoronavirus and Betacoronavirus. Consequently, a total of 30 pathogens were assessed against the relevance (B) and added value (C) criteria. At the end of the third Delphi round, group consensus (70%) was reached for 25 pathogens/diseases: five for inclusion and 20 for exclusion from WWS for the Paris 2024 OPG (Table 2). A summary of consensus reached per pathogen per round is available in Supplementary Table S2.

Additionally, five pathogens (measles virus, hepatitis A virus, *Vibrio cholerae*, norovirus and *Shigella* spp.) failed to reach the consensus threshold (70%). Given the increased risk of importation, transmission and dissemination of pathogens during the Games [6] and the notable increase in measles cases worldwide in 2023 and in Europe at the time of evaluation (February 2024) [19,20], measles virus was retained as a WWS target for Paris 2024. Moreover, the virus was only 1% (22/32) away from group consensus for inclusion in the final Delphi round. Conversely, hepatitis A virus and *Vibrio cholerae* were 1% (22/32) and 4% (21/32) away from exclusion, respectively. Group positions on norovirus and *Shigella* spp. were more evenly distributed (Table 3).

Ultimately, the other four were excluded based on their failure to satisfy the relevance and added value criteria. *Vibrio cholerae* WWS seems of little relevance in a high-income country such as France, characterised by access to safe chlorinated drinking-water, good sanitary conditions, and free healthcare. Indeed, in this setting, secondary transmission of *Vibrio cholera* is unlikely [21,22]. Noroviruses and *Shigella* spp. frequently circulate both in France and abroad [23,24]. Thus, detection would neither identify the source nor trigger specific public health measures. Finally, the lengthy incubation period for hepatitis A (15-50 days) limits the relevance of its wastewater monitoring within the brief timeframe of the Games [25]. A flowchart summarising the steps taken to identify priority pathogen targets for the 2024 OPG is available as Figure 2. The most relevant WWS objectives for pathogens retained are presented in Table 4.

Four diseases whose causative agents did not satisfy the analytical feasibility criterion were also proposed by the panel for assessment: tetanus (*Clostridium tetani*), plague (*Yersinia pestis*), tick-borne encephalitis (tick-borne encephalitis virus) and listeriosis (*Listeria monocytogenes*). These were added to the list of prospective pathogens for wastewater research. Those most frequently selected as research priorities across Delphi rounds were dengue virus (DENV), chikungunya virus (CHIKV) and West Nile virus (WNV), each receiving an average of 14, 14 and 11 votes, respectively. A full overview of expert opinion for this question is available in Supplementary Figure S1.

## Discussion

To our knowledge, this is the first study that uses expert opinion to prioritise pathogens for WWS during an international MG such as the OPG. The framework used identified six priority targets suitable for WWS during the Paris 2024 OPG: poliovirus, influenza A virus, influenza B virus, mpox virus, SARS-CoV-2 and measles virus. Expert opinion on pathogen-specific surveillance objectives such as detection, quantification, trend monitoring and assessment of genetic diversity was also gathered throughout the Delphi exercise. Such information is needed to frame the wastewater sampling strategy for the Games, notably with regards to sampling locations and frequencies.

The pertinence of priority targets identified highlights the strength of the method. Wastewater surveillance is one of the main tools recommended by the Global Polio Eradication Initiative (GPEI) to detect and monitor poliovirus circulation, including in polio-free countries such as France. Detection of the virus in such countries can act as an early warning system [3]. In 2022, the detection of type 2 vaccine-derived poliovirus in sewage samples in London, United Kingdom and New York City, United States (US) underscored the value of this surveillance [5,26]. It enabled the identification of the geographical area of virus circulation and informed the implementation of public health measures, e.g. enhanced surveillance, vaccination campaigns, etc.

Influenza A and B viruses represent a relevant public health burden, with worldwide distribution and year-round circulation. Epidemics typically occur between November and April in the northern hemisphere, and between June and October in the southern hemisphere [27]. Wastewater surveillance has been shown to accurately reflect the seasonal onset and prevalence of influenza, even outperforming clinical surveillance [28]. Integrating WWS during the 2024 OPG could provide valuable insight into the background circulation of influenza A and B viruses in Paris during summer months and facilitate tracking of potential transmission chains of the viruses imported by travellers from the southern hemisphere. Elevated virus titres in wastewater could, in turn, prompt increased testing and diagnosis of influenza cases, which might otherwise be misdiagnosed. For instance, an influenza case could be mistaken for a COVID-19 case if SARS-CoV-2 circulation is ongoing.

Wastewater surveillance has been found to have relatively high sensitivity to detect even a small number of cases of mpox virus infections [29] and the potential to provide early detection of virus circulation in non-endemic countries [30]. Further, wastewater data can be used alongside clinical surveillance data to deliver better estimates of the scale of epidemics. Mpox virus has been detected in wastewater both at disproportionately high levels when compared with identified cases, as well as in the absence of reported cases [31]. Indeed, the social stigma related to the higher

<figure><img src="image_10.png" /></figure>
FIGURE 2

<figure><img src="image_11.png" /><figcaption>Flowchart summarising steps taken to identify priority targets for wastewater surveillance during the Paris 2024 Olympic and Paralympic Games, France</figcaption></figure>

MERS-CoV 2: Middle East respiratory syndrome coronavirus; SARS-CoV-1: severe acute respiratory syndrome coronavirus 1; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; SpF: Santé publique France.

<figure><img src="image_12.png" /></figure>
TABLE 2

<table><caption>Summary of results from evaluation of 30 potential pathogens for wastewater surveillance during the Paris 2024 Olympic and Paralympic Games following the 3-round Delphi survey, France, May–July 2023</caption><thead><tr><th colspan="2">Potential wastewater surveillance targets</th><th colspan="4">Inclusion criteria</th><th rowspan="2">Pathogens retained</th><th rowspan="2">Pathogens excluded</th><th rowspan="2">Pathogens for which no consensus was found</th></tr><tr><th>Pathogen genus/disease</th><th>Pathogen species/genogroup</th><th colspan="3">Pertinence</th><th>Plus-value to inform public health action</th></tr><tr><th></th><th></th><th>Specificities of the event</th><th>Pathogen-/disease-specific characteristics</th><th></th><th></th><th></th><th></th><th></th></tr></thead><tbody><tr><td colspan="9"><strong>Vaccine-preventable diseases</strong></td></tr><tr><td>Measles</td><td>Measles virus (MV)</td><td>NA</td><td>NA</td><td>NA</td><td>-</td><td>-</td><td>1</td><td>-</td></tr><tr><td>Poliomyelitis</td><td>Poliovirus</td><td>Yes</td><td>Yes</td><td>Yes</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td colspan="9"><strong>Food- and waterborne diseases</strong></td></tr><tr><td>Adenovirus</td><td>Human adenovirus-F (HAdV-F)</td><td>No (39%; 11/28)</td><td>No (46%; 13/28)</td><td>No (75%; 21/28)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Amoebiasis</td><td>Entamoeba histolytica</td><td>No (56%; 14/25)</td><td>No (52%; 13/25)</td><td>No (56%; 14/25)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Campylobacter infections</td><td>17 species have been identified, of which C. jejuni and C. coli are most frequently reported in human disease</td><td>No (37%; 10/27)</td><td>No (56%; 15/27)</td><td>No (74%; 20/27)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Cholera</td><td>Vibrio cholerae</td><td>NA</td><td>NA</td><td>NA</td><td>-</td><td>-</td><td>1</td><td>-</td></tr><tr><td>Cryptosporidium</td><td>C. hominis, C. parvum, C. meleagridis, C. muris</td><td>No (42%; 10/24)</td><td>No (46%; 11/24)</td><td>No (75%; 18/24)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Escherichia coli infections</td><td>Escherichia coli</td><td>No (48%; 14/29)</td><td>No (72%; 21/29)</td><td>No (76%; 22/29)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Giardia</td><td>G. duodenalis</td><td>No (39%; 11/28)</td><td>No (50%; 14/28)</td><td>No (68%; 19/28)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Hepatitis A</td><td>Hepatitis A virus (HAV)</td><td>NA</td><td>NA</td><td>NA</td><td>-</td><td>-</td><td>1</td><td>-</td></tr><tr><td>Hepatitis E</td><td>Hepatitis E virus (HEV)</td><td>No (32%; 9/28)</td><td>No (36%; 10/28)</td><td>No (82%; 23/28)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Legionnaires' disease</td><td>20 species have been documented as human pathogens, of which L. pneumophila most commonly causes of illness humans</td><td>No (44%; 11/25)</td><td>No (56%; 14/25)</td><td>No (64%; 16/25)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Non-polio enterovirus</td><td>Enterovirus A, B, C and D</td><td>No (44%; 11/25)</td><td>No (28%; 7/25)</td><td>No (84%; 21/25)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Norovirus</td><td>GI, GII and GIV</td><td>NA</td><td>NA</td><td>NA</td><td>-</td><td>-</td><td>1</td><td>-</td></tr><tr><td>Rotavirus</td><td>Rotavirus A</td><td>No (33%; 8/24)</td><td>No (58%; 14/24)</td><td>No (71%; 17/24)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Salmonellosis (Nontyphoidal Salmonella)</td><td>Salmonella bongori, Salmonella enterica</td><td>No (41%; 12/29)</td><td>No (72%; 21/29)</td><td>No (83%; 24/29)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Shigellosis</td><td>Shigella sonnei, Shigella flexneri, Shigella boydii, Shigella dysenteriae</td><td>NA</td><td>NA</td><td>NA</td><td>-</td><td>-</td><td>1</td><td>-</td></tr><tr><td>Yersiniosis</td><td>Yersinia enterocolitica</td><td>No (44%; 12/27)</td><td>No (48%; 13/27)</td><td>No (59%; 16/27)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td colspan="9"><strong>Respiratory diseases</strong></td></tr><tr><td>Alphacoronavirus</td><td>HCoV-229E</td><td>No (26%; 7/27)</td><td>No (59%; 16/27)</td><td>No (74%; 20/27)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Betacoronavirus</td><td>Betacoronavirus 1, HCoV-HKU1</td><td>No (26%; 7/27)</td><td>No (63%; 17/27)</td><td>No (67%; 18/27)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td rowspan="2">Influenza</td><td>Influenza A virus</td><td>Yes</td><td>Yes</td><td>Yes</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Influenza B virus</td><td>Yes</td><td>Yes</td><td>Yes</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Tuberculosis</td><td>Mycobacterium tuberculosis complex</td><td>No (61%; 14/23)</td><td>No (70%; 16/23)</td><td>No (48%; 11/23)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td colspan="9"><strong>Emerging and vector-borne diseases</strong></td></tr><tr><td>COVID-19</td><td>SARS-CoV-2</td><td>Yes</td><td>Yes</td><td>Yes</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Ebola</td><td>Zaire ebolavirus (EBOV), Sudan ebolavirus (SUDV), Tai Forest ebolavirus (TAFV), Bundibugyo ebolavirus (BDBV)</td><td>No (56%; 14/25)</td><td>No (80%; 20/25)</td><td>No (80%; 20/25)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Mpox</td><td>MPXV</td><td>Yes</td><td>Yes</td><td>Yes</td><td>1</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Severe acute respiratory syndrome (SARS)</td><td>SARS-CoV-1</td><td>No (28%; 7/25)</td><td>No (68%; 17/25)</td><td>No (40%; 10/25)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td colspan="9"><strong>Zoonoses</strong></td></tr><tr><td>Echinococcosis</td><td>Echinococcus multilocularis</td><td>No (53%; 16/30)</td><td>No (73%; 22/30)</td><td>No (37%; 11/30)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td>Leptospirosis</td><td>64 species have been identified</td><td>No (44%; 11/24)</td><td>No (63%; 15/24)</td><td>No (58%; 14/24)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td colspan="9"><strong>Sexually transmitted infections</strong></td></tr><tr><td>Human immunodeficiency virus (HIV) infection</td><td>Human immunodeficiency virus 1 (HIV-1), Human immunodeficiency virus 2 (HIV-2)</td><td>No (50%; 15/30)</td><td>No (60%; 18/30)</td><td>No (70%; 21/30)</td><td>-</td><td>1</td><td>-</td><td>-</td></tr><tr><td><strong>Total</strong></td><td></td><td></td><td></td><td></td><td>5</td><td>20</td><td>5</td><td></td></tr></tbody></table>

COVID-19: coronavirus disease; NA: not applicable.

Where group consensus resulted in the exclusion of pathogens, the cumulative responses of experts regarding the criterion/criteria influencing this decision are enclosed within brackets. Since only the experts who voted for exclusion were asked this question, the denominator reflects the number of experts who voted accordingly. A summary of consensus reached per pathogen per round is available in Supplementary Table S2.

<figure><img src="image_13.png" /></figure>
<table><caption>TABLE 3</caption><caption>Expert opinion on five pathogens failing to reach the 70% consensus threshold for wastewater surveillance during the Paris 2024 Olympic and Paralympic Games following the third round of the Delphi survey, France, May–July 2023 (n = 32 experts)</caption></table>

<table><thead><tr><th rowspan="2">Pathogen</th><th colspan="2">Inclusion</th><th colspan="2">Exclusion</th></tr><tr><th>%</th><th>n</th><th>%</th><th>n</th></tr></thead><tbody><tr><td>Measles virus</td><td>69</td><td>22</td><td>31</td><td>10</td></tr><tr><td>Vibrio cholerae</td><td>34</td><td>11</td><td>66</td><td>21</td></tr><tr><td>Norovirus</td><td>56</td><td>18</td><td>44</td><td>14</td></tr><tr><td>Shigella spp.</td><td>44</td><td>14</td><td>56</td><td>18</td></tr><tr><td>Hepatitis A virus</td><td>31</td><td>10</td><td>69</td><td>22</td></tr></tbody></table>

incidence of mpox among men who have sex with men (MSM) is believed to contribute to its underdiagnosis [30,31]. This trend may be exacerbated among foreign tourists during the OPG.

Wastewater surveillance of SARS-CoV-2 has proven useful in informing public health actions during the COVID-19 pandemic, notably by: (i) validating trends observed through other data sources; (ii) informing the allocation of resources, e.g. personnel, hospital beds, screening sites, vaccination sites; and (iii) guiding the implementation of prevention and control measures, e.g. mask wearing, social distancing [1,4]. Finally, measures virus was deemed of special interest for WWS during the Games given the epidemiological situation in Europe and internationally at the time of evaluation (February 2024) [19,20] and increased risk of virus circulation during the Games [6].

Wastewater-based epidemiology is a field that has developed considerably since 2020, though many uncertainties remain. While it has been shown that multiple variables including pathogen-specific structural characteristics (presence of a lipid envelope, affinity with organic matter), and environmental parameters (temperature, pH and biological activity) affect the persistence of pathogens in the environment, our understanding of pathogen shedding dynamics and stability in wastewater remains limited [15]. To account for this, we considered the analytical feasibility criterion met if there was published evidence that a given pathogen has been detected in wastewater previously. Nonetheless, it is possible that pathogens of interest were excluded based on the wrongful assumption that they cannot be detected in wastewater. Potential pathogens should be reviewed in the light of the global health situation and new emerging diseases should be considered. The example of mpox is very illustrative in this respect, with a recent (re)emergence in 2022–23 followed by a prompt adaptation of WWS systems, notably in the United States [32]. We recommend that this criterion be reassessed regularly as knowledge in the field progresses.

The solicitation of expert opinion via the Delphi method is useful in areas where knowledge is incomplete and objective data are unavailable [17,18]. Although judgments made based on the collective opinions of the members of a group are often better than those made by a single member, relying on expert opinion can present certain limitations. Firstly, the quality of conclusions is limited by the expertise of panel members. Further, the success of the Delphi process depends on the impartial judgment of participants [17]. For this reason, particular attention was paid to the choice of experts invited to take part in this exercise, especially with regard to their potential conflicts of interest and qualifications. Although WBE is an interdisciplinary field, determining whether a given pathogen is a suitable WWS target for the OPG is fundamentally a public health question. This explains the high proportion of public health experts who made up our expert panel (26/32). Further, special care was taken to ensure that panellists selected for their experience in microbiology and drinking-water/wastewater treatment also possessed competencies in public health or WBE, allowing them to fully leverage their knowledge within the project's scope. This, along with the initial pathogen screening based on analytical feasibility carried out prior to the Delphi exercise, justifies the smaller representation of microbiology (9/32) and drinking-water/wastewater treatment (4/32) professionals among panellists.

Studies have shown that Delphi groups that receive feedback on why participants opted for certain responses in addition to quantitative analyses of respondent data reach more accurate conclusions than groups that receive only response statistics [18]. Consequently, experts were given the opportunity to leave comments at every step of the survey process. This information was summarised and provided to all participants at the start of each new round.

This pathogen prioritisation exercise and the information gathered throughout its course aimed to serve as a starting point for a WWS plan for the Paris 2024 OPG. However, more work is needed before an implementation. In France, WWS operates through the SUM'Eau network, which monitors SARS-CoV-2 circulation in 54 wastewater treatment plants nationwide. A WWS plan for the Games would leverage this existing system. At the time of writing, a wastewater sampling strategy proposal based on the conclusion of this study was under review by the French health authorities. Upon approval, the next steps will include the selection of operators in charge of sampling and partner laboratories that will perform analyses. For certain pathogens, laboratory methods will need to be developed for detection and quantification. Methods will also need to be optimised in terms of time efficiency and cost-effectiveness. In addition, technical feasibility constraints may necessitate adjustments to the sampling strategy and could warrant further refinement of pathogen targets and/or WWS objectives. A WWS plan for Paris 2024 OPG would serve as an exploratory tool, providing proof of

<figure><img src="image_14.png" /></figure>
TABLE 4

Expert opinion on the most relevant surveillance objectives for the six priority pathogen targets identified for wastewater surveillance during the Paris 2024 Olympic and Paralympic Games, France

<table><thead><tr><td>Pathogen</td><td>Detection (presence/absence)</td><td>Quantification</td><td>Trend monitoring</td><td>Assessment of genetic diversity</td></tr></thead><tbody><tr><td>Poliovirus</td><td>100%</td><td>29%</td><td>21%</td><td>68%</td></tr><tr><td>Influenza A virus</td><td>52%</td><td>65%</td><td>82%</td><td>65%</td></tr><tr><td>Influenza B virus</td><td>56%</td><td>61%</td><td>65%</td><td>56%</td></tr><tr><td>Mpox virus</td><td>86%</td><td>53%</td><td>71%</td><td>29%</td></tr><tr><td>SARS-CoV-2</td><td>47%</td><td>70%</td><td>90%</td><td>87%</td></tr><tr><td>Measles virus</td><td>95%</td><td>23%</td><td>50%</td><td>32%</td></tr></tbody></table>

SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

The data presented correspond to the responses of the sub-section of participants who voted for these pathogens to be included as targets for WWS during the Paris 2024 Olympic and Paralympic Games either: (i) in the Delphi round in which consensus was reached for their inclusion (for pathogens retained) (Supplementary Table S2) or (ii) at the end of the third round of the Delphi survey (for pathogens which failed to reach group consensus, but were retained, i.e. measles virus).

concept for monitoring measles virus, influenza A virus and influenza B virus in Parisian wastewaters.

In considering possible future research directions, the Delphi rounds also collected expert opinion on which of the 29 pathogens excluded based on a lack of evidence of detectability in wastewater (analytical feasibility criterion), should constitute research priorities. Among the most frequently selected (DENV, CHIKV and WNV), all were arboviruses. This can be explained by the increasing risk of mosquito-borne diseases in Europe following the spread of *Aedes* species. The impact of climate change on the continent has been marked with more frequent heat waves and flooding as well as longer and warmer summers. These changing weather patterns are creating favourable conditions for invasive mosquito species like *Aedes albopictus* (known to transmit DENV, CHIKV, yellow fever virus and Zika virus) to thrive [33].

Over the last few decades, the World has seen a global rise in human infectious disease outbreaks [34]. Environmental changes themselves linked to anthropogenic activities are modifying ecosystems' structure and composition as well as interactions between host, pathogen, and the environment. Human behaviour, demographic changes, globalisation, and international travel are bringing people in closer and more frequent contact with pathogens, facilitating their dissemination. In addition, the evolution and selection for resistant microorganisms suggest that communicable diseases will continue to spread and emerge [35,36]. Given the inevitability that pathogens with epidemic potential will threaten public health again, the development of new cost-effective public health monitoring tools, such as WWS, seems not only relevant, but essential.

## Conclusion

This study introduced a model framework for identifying context specific WWS targets for an MG event. A successful WWS plan for the Paris 2024 OPG and the lessons learned from its design and implementation should have a notable impact on the development of

the field of WBE. Notably, it could facilitate the extension of France's routine WWS to other pathogens, and act as both an incentive and a starting point for the implementation of such surveillance during other MGs globally.

## Ethical statement

Prior to their involvement, individuals invited to participate in the Delphi exercise were briefed on the study's objectives and assured of the confidentiality and anonymity of their contributions. Given the absence of direct subject interaction, personal identifying information, or foreseeable risks to participants, we deemed formal ethical approval unnecessary for this study.

## Funding statement

Not applicable.

## Use of artificial intelligence tools

None declared.

## Data availability

Not applicable.

## Acknowledgements

The authors wish to acknowledge all the experts who participated in the Delphi exercise for their invaluable contributions to this study. We would also like to extend special thanks to Zoé Senta-Loïys and Walid Mokni from the French Directorate-General for Health, as well as Ami Yamada, Deputy Director of the Regional Offices of Santé Publique France, for their support.

## Conflict of interest

None declared.

<figure><img src="image_15.png" /></figure>
Authors' contributions

The study was designed by LT, FJ and DM. LT conducted the literature search, piloted the data collection, and performed analyses, with supervision from FJ and DM. FJ, HdV and AA contributed to the literature search. All authors (LT, HdV, LZ, CH, AT, NF, LM, AA, BG, DM and FJ) participated in data analysis and interpretation. LT drafted a preliminary version of the manuscript, which was revised by DM and FJ to create an initial article draft. Subsequently, all authors reviewed the draft and provided feedback. All authors participated in editing and approving the final version of the manuscript.

References

1. World Health Organization (WHO). Environmental surveillance for SARS-CoV-2 to complement other public health surveillance. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/item/9789240080638

2. Choi PM, Tscharke BJ, Donner E, Grant SC, Kaserzon SL, Mackie R, et al. Wastewater-based epidemiology biomarkers: Past, present and future. Trends Analyt Chem. 2018;105:453-69. https://doi.org/10.1016/j.trac.2018.06.004

3. World Health Organization (WHO), Global Polio Eradication Initiative. Field guidance for the implementation of environmental surveillance for poliovirus 2023. Geneva: WHO; 2023. Available from: https://iris.who.int/handle/10665/368833

4. National Academies of Sciences, Engineering, and Medicine. Wastewater-based Disease Surveillance for Public Health Action. Washington, D.C.: National Academies Press; 2023.

5. Klapsa D, Wilton T, Zealand A, Bujaki E, Saxentoff E, Troman C, et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. 2022;400(10362):1531-8. https://doi.org/10.1016/S0140-6736(22)01804-9 PMID: 36243024

6. World Health Organization (WHO). Public health for mass gatherings: key considerations 2015. Geneva: WHO; 2015. Available from: https://www.who.int/publications/i/item/public-health-for-mass-gatherings-key-considerations

7. European Centre for Disease Prevention and Control (ECDC). Public health risks related to communicable diseases at the Rio de Janeiro Olympic and Paralympic Games, Brazil 2016 - 1st update, 13 June 2016. Stockholm: ECDC; 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/public-health-risks-related-communicable-diseases-rio-de-janeiro-olympic-and

8. Decludt B, Guillotin L, van Gastel B, Perrocheau A, Capek L, Ledrans M, et al. Foyer épidémique de légionelles à Paris en juin 1998. Euro Surveill. 1999;4:115-8. https://doi.org/10.2807/esm.04.11.00060-en PMID: 12631883

9. Wilder-Smith A, Goh KT, Barkham T, Paton NI. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis. 2003;36(6):679-83. https://doi.org/10.1086/367858 PMID: 12627350

10. Schenkel K, Williams C, Eckmanns T, Poggensee G, Benzler J, Josephsen J, et al. Enhanced Surveillance of Infectious Diseases: the 2006 FIFA World Cup experience, Germany. Euro Surveill. 2006;11(12):15-6. https://doi.org/10.2807/esm.11.12.00670-en PMID: 29208141

11. Gardy JL, Naus M, Amlani A, Chung W, Kim H, Tan M, et al. Whole-genome sequencing of measles virus genotypes H1 and D8 during outbreaks of infection following the 2010 Olympic Winter Games reveals viral transmission routes. J Infect Dis. 2015;212(10):1574-8. https://doi.org/10.1093/infdis/jiv271 PMID: 26153409

12. International Olympic Committee (IOC). Paris 2024 Olympic Games. Paris: IOC. [Accessed: 15 Aug 2023]. Available from: https://www.paris2024.org/en/the-olympic-games-paris-2024

13. Office du Tourisme et des Congrès de Paris. Note de synthèse: Fréquentation: qu'attendre des Jeux Olympiques et Paralympiques de Paris 2024. [Summary: Attendance: what to expect from the Games Paris 2024 Olympics and Paralympics]. Paris: Paris je t'aime - Office de Tourisme; 2023. French. Available from: https://www.etoa.org/wp-content/uploads/2022/07/Paris.SynthesePrevisions-JOP2024.pdf

14. Eaton C, Coxon S, Pattis I, Gilpin B. Wastewater-based epidemiology: A framework to identify and prioritise health. The Institute of Environmental Science and Research Limited; 2021. Available from: https://www.esr.cri.nz/digital-library/

wastewater-based-epidemiology-a-framework-to-identify-and-prioritise-health-determinants-for-wastewater-monitoring

15. Robins K, Leonard AFC, Farkas K, Graham DW, Jones DL, Kasprzyk-Hordern B, et al. Research needs for optimising wastewater-based epidemiology monitoring for public health protection. J Water Health. 2022;20(9):1284-313. https://doi.org/10.2166/wh.2022.026 PMID: 36170187

16. World Health Organization (WHO). Surveillance, case investigation and contact tracing for mpox (monkeypox): interim guidance, 22 December 2022. Geneva: WHO; 2022. Available from: https://iris.who.int/bitstream/handle/10665/365398/WHO-MPX-Surveillance-2022.4-eng.pdf?sequence=1

17. Niederberger M, Spranger J. Delphi technique in health sciences: a map. Front Public Health. 2020;8:457. https://doi.org/10.3389/fpubh.2020.00457 PMID: 33072683

18. Hallowell MR. Techniques to minimize bias when using the Delphi method to quantify construction safety and health risks. In: Building a Sustainable Future, pages 1489-98. 2012.

19. United Nations Regional Information Centre for Western Europe. WHO: "Alarming" rise of measles cases in Europe. Brussels: United Nations Western Europe; 2024. Available from: https://unric.org/en/who-alarming-rise-of-measles-cases-in-europe

20. Moniuszko S. Measles cases rose 79% globally last year, WHO says. Experts explain why. CBS News 2024. Available from: https://www.cbsnews.com/news/measles-cases-rose-worldwide-2023-who

21. Tarantola A, Quatresous I, Paquet C. Risk and control of imported cholera in a high-income country. Lancet Infect Dis. 2008;8(5):270-1. https://doi.org/10.1016/S1473-3099(08)00703-2 PMID: 18471765

22. Corso M, Galey C, Seux R, Beaudieu P. An assessment of current and past concentrations of trihalomethanes in drinking water throughout France. Int J Environ Res Public Health. 2018;15(8):1669. https://doi.org/10.3390/ijerph15081669 PMID: 30082664

23. Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (Anses). Comment éviter les intoxications alimentaires liées aux norovirus? Maisons-Alfort: Anses; 2023. Available from: https://www.anses.fr/fr/content/eviter-intoxications-alimentaires-norovirus

24. Institut Pasteur. Shigellose. Institut Pasteur; 2015. Available from: https://www.pasteur.fr/fr/centre-medical/fiches-maladies/shigellose

25. Public Health Agency of Canada. Pathogen Safety Data Sheets: Infectious Substances – Hepatitis A virus (HAV). Ottawa: Government of Canada; 2011. Available from: https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/hepatitis-a-virus.html

26. Ryerson AB, Lang D, Alazawi MA, Neyra M, Hill DT, St George K, et al. Wastewater testing and detection of poliovirus type 2 genetically linked to virus isolated from a paralytic polio case - New York, March 9-October 11, 2022. Atlanta: Centers for Disease Control and Prevention; 2022. MMWR Morb Mortal Wkly Rep. 2022;71(44):1418-24. https://doi.org/10.15585/mmwr.mm7144e2 PMID: 36327157

27. European Centre for Disease Prevention and Control (ECDC). Factsheet about seasonal influenza. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/seasonal-influenza/facts/factsheet

28. Dlamini M, Msolo L, Ehi Ebomah K, Nontongana N, Ifeanyi Okoh A. A systematic review on the incidence of influenza viruses in wastewater matrices: Implications for public health. PLoS One. 2024;19(4):e0291900. https://doi.org/10.1371/journal.pone.0291900 PMID: 38662758

29. Adams C, Kirby AE, Bias M, Riser A, Wong KK, Mercante JW, et al. Detecting mpox cases through wastewater surveillance - United States, August 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2024;73(2):37-43. https://doi.org/10.15585/mmwr.mm7302a3 PMID: 38236784

30. Tiwari A, Adhikari S, Kaya D, Islam MA, Malla B, Sherchan SP, et al. Monkeypox outbreak: Wastewater and environmental surveillance perspective. Sci Total Environ. 2023;856(Pt 2):159166. https://doi.org/10.1016/j.scitotenv.2022.159166 PMID: 36202364

31. Gazecka M, Sniezek J, Maciolek K, Kowala-Piaskowska A, Zmora P. Mpox virus detection in the wastewater and the number of hospitalized patients in the Poznan metropolitan area, Poland. Int J Infect Dis. 2023;133:75-7. https://doi.org/10.1016/j.ijid.2023.05.014 PMID: 37196758

32. Adams C, Bias M, Welsh RM, Webb J, Reese H, Delgado S, et al. The National Wastewater Surveillance System (NWSS): From inception to widespread coverage, 2020-2022, United States.

<figure><img src="image_16.png" /></figure>
Sci Total Environ. 2024;924:171566. https://doi.org/10.1016/j.scitotenv.2024.171566 PMID: 38461979

33. European Centre for Disease Prevention and Control (ECDC). Increasing risk of mosquito-borne diseases in EU/EEA following spread of Aedes species. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/news-events/increasing-risk-mosquito-borne-diseases-eueea-following-spread-aedes-species

34. Hamouda M, Mustafa F, Maraqa M, Rizvi T, Aly Hassan A. Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications. Sci Total Environ. 2021;759:143493. https://doi.org/10.1016/j.scitotenv.2020.143493 PMID: 33190883

35. Daszak P, das Neves C, Amuasi J, Haymen D, Kuiken T, Roche B, et al. Workshop report on biodiversity and pandemics of the Intergovernmental Platform on Biodiversity and Ecosystem Services Bonn: Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES); 2020. Available from: https://zenodo.org/records/7432079

36. Dufour B. Les causes de l'émergence des maladies infectieuses [The causes of the emergence of infectious diseases]. Bull Acad Natl Med. 2017;201(7):1189-95. https://doi.org/10.1016/S0001-4079(19)30410-8 PMID: 32226057

37. Hoang VT, Al-Tawfiq JA, Gautret P. The Tokyo Olympic Games and the Risk of COVID-19. Curr Trop Med Rep. 2020;7(4):126-32. https://doi.org/10.1007/s40475-020-00217-y PMID: 33145147

38. McCloskey B, Endericks T, Catchpole M, Zambon M, McLauchlin J, Shetty N, et al. London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology. Lancet. 2014;383(9934):2083-9. https://doi.org/10.1016/S0140-6736(13)62342-9 PMID: 24857700

39. World Health Organization (WHO). Prioritizing diseases for research and development in emergency contexts. Geneva: WHO. Available from: https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts

40. Economopoulou A, Kinross P, Domanovic D, Coulombier D. Infectious diseases prioritisation for event-based surveillance at the European Union level for the 2012 Olympic and Paralympic Games. Euro Surveill. 2014;19(15):20770. https://doi.org/10.2807/1560-7917.ES2014.19.15.20770 PMID: 24762663

41. National Institute of Infectious Diseases, Center for Emergency Preparedness and Response, Center for Field Epidemic Intelligence, Research and Professional Development, Center for Surveillance, Immunization, and Epidemiologic Research. Infectious Disease Risk Assessment for the Tokyo Olympic and Paralympic Games (Updated Version). Tokyo: NIID; 2021. Available from: https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10471-covid19-45.html

## License, supplementary material and copyright

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence and indicate if changes were made.

Any supplementary material referenced in the article can be found in the online version.

This article is copyright of the authors or their affiliated institutions, 2024.

<figure><img src="image_17.png" /></figure>